- Home
- AVDL vs SBH Comparison
AVDL vs SBH Comparison
Compare AVDL & SBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- SBH
- Stock Information
- Founded
- AVDL 2015
- SBH 1964
- Country
- AVDL Ireland
- SBH United States
- Employees
- AVDL N/A
- SBH N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- SBH Other Specialty Stores
- Sector
- AVDL Health Care
- SBH Consumer Discretionary
- Exchange
- AVDL Nasdaq
- SBH Nasdaq
- Market Cap
- AVDL 900.2M
- SBH 937.3M
- IPO Year
- AVDL 1996
- SBH 2006
- Fundamental
- Price
- AVDL $9.54
- SBH $9.82
- Analyst Decision
- AVDL Strong Buy
- SBH Buy
- Analyst Count
- AVDL 6
- SBH 6
- Target Price
- AVDL $18.17
- SBH $12.70
- AVG Volume (30 Days)
- AVDL 1.6M
- SBH 1.7M
- Earning Date
- AVDL 08-07-2025
- SBH 08-07-2025
- Dividend Yield
- AVDL N/A
- SBH N/A
- EPS Growth
- AVDL N/A
- SBH 18.05
- EPS
- AVDL N/A
- SBH 1.76
- Revenue
- AVDL $194,450,000.00
- SBH $3,698,409,000.00
- Revenue This Year
- AVDL $56.88
- SBH N/A
- Revenue Next Year
- AVDL $29.81
- SBH $1.40
- P/E Ratio
- AVDL N/A
- SBH $5.60
- Revenue Growth
- AVDL 252.64
- SBH 0.17
- 52 Week Low
- AVDL $6.38
- SBH $7.54
- 52 Week High
- AVDL $17.30
- SBH $14.79
- Technical
- Relative Strength Index (RSI)
- AVDL 56.42
- SBH 59.63
- Support Level
- AVDL $8.74
- SBH $9.80
- Resistance Level
- AVDL $9.56
- SBH $10.32
- Average True Range (ATR)
- AVDL 0.39
- SBH 0.34
- MACD
- AVDL 0.04
- SBH 0.07
- Stochastic Oscillator
- AVDL 81.92
- SBH 69.95
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.